.AstraZeneca has shared an early examine the performance of its own internal antibody-drug conjugate...
.After announcing a phase 3 launch based upon good midstage results, iTeos and also GSK are finally ...
.The FDA should be more open and collaborative to release a rise in approvals of unusual health cond...
.It's an extraordinarily hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bi...
.Atea Pharmaceuticals' antiviral has actually fallen short one more COVID-19 test, however the biote...
.Neurocrine Biosciences' schizophrenia plan pivot has actually stopped working. The biotech was unab...
.Sanofi has actually brought in an overdue entry to the radioligand event, spending 100 thousand eur...
.After F2G's very first try to acquire a new class of antifungal to market was actually wrecked by t...
.Moderna has promised to reduce R&D costs by $1.1 billion through 2027. The selection to shrink t...
.Only four months after Sanofi bet $80 thousand in upfront cash money on Key Rehabs' losmapimod, the...